Spots Global Cancer Trial Database for Quantitative MR Biomarkers for Sarcoma Treatment
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Quantitative MR Biomarkers for Sarcoma Treatment
Official Title: Quantitative MR Biomarkers for Sarcoma Treatment
Study ID: NCT01017978
Conditions
Interventions
Study Description
Brief Summary: To determine if MRI imaging can be used to accurately determine if a sarcoma is responding to the type of chemotherapy being used.
Detailed Description: The purpose of this study is to determine if MRI imaging can be used to accurately determine if a sarcoma is responding to the type of chemotherapy being used or if it is ineffective early on in the treatment; instead of finding this out 2-3 months later. If it is determined that MRI can accurately diagnose tumor response, medications can be switched early on potentially improv8ing the patients'chances of recovery.
Keywords
Eligibility
Minimum Age: 3 Years
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University of Michigan Health System, Ann Arbor, Michigan, United States
Contact Details
Name: Gary Luker, M.D.
Affiliation: Universityof Michigan Health Systems
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
